Bellini Roberto 4
4 · Inhibikase Therapeutics, Inc. · Filed Oct 23, 2024
Insider Transaction Report
Form 4
Bellini Roberto
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-21+60,000→ 60,000 totalExercise: $2.22Exp: 2034-10-21→ Common Stock (60,000 underlying) - Purchase
Common Stock
2024-10-21$1.37/sh+1,460,000$2,000,200→ 1,460,000 total(indirect: See footnote)
Footnotes (2)
- [F1]These securities are owned directly by BSQUARED CAPITAL INC ("BSQ"). Mr. Bellini is a shareholder and officer of BSQ. Mr. Bellini expressly disclaims beneficial ownership of the securities listed above except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]The option shares vest 50% on each of the first two anniversaries of October 21, 2024.